search
Back to results

efficAcy and Safety of Home-baSed Cardiac rehabIlitation in ChineSe Revascularized patienTs (ASSIST)

Primary Purpose

Coronary Artery Disease

Status
Unknown status
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
home-based cardiac rehabilitation
Sponsored by
Chinese PLA General Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Coronary Artery Disease focused on measuring cardiorespiratory fitness, coronary artery disease, cardiac rehabilitation, remote control, major adverse cardiac and cerebrovascular events

Eligibility Criteria

30 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

all of them

  1. age range from 30 to 80.
  2. coronary artery disease,revascularized with stent deployment.
  3. New York Heart Association (NYHA) classification Class I-III.
  4. Good cognitive level.
  5. Ability to perform aerobic exercise.
  6. Understand be able to use a mobile smart phone by himself or with help of family members.
  7. Signature of informed consent. The informed consent will be valid for the duration of the trial or until the subject withdraws.

Exclusion Criteria (Enrollment):

  1. Presence of malignant arrhythmias such as ventricular fibrillation outside the acute phase of Acute myocardial infarction (AMI) (> 24 h after AMI), ventricular tachycardia, Atrioventricular block of 2nd degree and 3rd degree, Atrial fibrilation (FA) in patients with Wolf Parkinson White, fibrillation or paroxysmal atrial flutter with response ventricular quickly and hemodynamic deterioration, premature ventricular contractions increases during exertion, paroxysmal supraventricular tachycardia uncontrolled.
  2. Hypotensive response to exercise.
  3. acute myocardial infarction within 2 weeks
  4. Poorly controlled hypertension baseline,hyperglycemia,respiratory failure.
  5. severe pulmonary hypertension
  6. acute phase of heart failure
  7. Pathology of musculoskeletal, neurological or breathing that impair the ability of prolonged ambulation.
  8. Pregnant women.
  9. Subjects unable to give informed consent.

Sites / Locations

  • the First People's Hospital of Yunnan ProvinceRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Home-based Cardiac Rehabilitation group

routine group

Arm Description

remote instructed exercise training at home

no instructed exercise training

Outcomes

Primary Outcome Measures

MACCE(death, nonfatal myocardial infarction, revascularization, stroke)
defined as the incidence of composite MACCE.

Secondary Outcome Measures

improvement of hospitalization due to refractory angina pectoris
improvement of hospitalization due to refractory angina pectoris which need to be treated in hospital
improvement of cardiorespiratory fitness
peak oxygen uptake adjusted by body weight measured by cardiopulmonary exercise test
improvement of life quality
measured by medical outcomes study 36-item short form health survey
improvement of angina pectoris
measured by Seattle Angina Questionnaire.

Full Information

First Posted
March 25, 2017
Last Updated
April 15, 2019
Sponsor
Chinese PLA General Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT03102346
Brief Title
efficAcy and Safety of Home-baSed Cardiac rehabIlitation in ChineSe Revascularized patienTs
Acronym
ASSIST
Official Title
A Perspective Randomized Controlled Clinical Trial to Investigate the Effect of Home-based Cardiac Rehabilitation Monitored by Mobile Phone Interaction on Exercise Capacity and One-year Clinical Outcome in Chinese Revascularized Patients
Study Type
Interventional

2. Study Status

Record Verification Date
April 2019
Overall Recruitment Status
Unknown status
Study Start Date
November 9, 2017 (Actual)
Primary Completion Date
August 2021 (Anticipated)
Study Completion Date
December 2021 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Chinese PLA General Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Home-based CR (HBCR) was reported to improve the clinical outcomes of coronary artery disease (CAD) patients. There is no data published to investigate whether HBCR is also effective for Chinese CAD patients who have been revascularized. This trial was designed to investigate the safety and efficacy of CR program at home for Chinese patients who underwent PCI (Percutaneous Coronary Intervention) procedure. This is a multicenter, randomized, controlled and observational study.
Detailed Description
Numerous studies have revealed that cardiac rehabilitation (CR) after myocardial Cardiac rehabilitation (CR) after revascularization results in better clinical outcomes, and have been strongly recommended for patients with coronary artery disease. In China, as compared to the exponential increase of PCI (Percutaneous Coronary Intervention) volume, only a very small amount of hospitals are able to develop CR programs. There is no large-scale study to explore the feasible CR pattern either. Home-based CR might be more favorable and practical for so many Chinese revascularized coronary artery disease (CAD) patients due to its feasibility and flexibility as well as low medical cost. This trial was designed to investigate the safety and efficacy of CR program at home for Chinese patients who underwent PCI procedure. This is a multicenter, randomized, controlled and observational study. The efficacy and safety of Home-based CR (HBCR) in revascularized patients will be evaluated through observation of its clinical characteristics and safety indicators. The study will involve 14 sites nationwide, with an expected sample size of 2,000 followed up for 12 months. The primary endpoints is the incidence of composite major adverse cardiac and cerebrovascular events (MACCE,death from any cause, nonfatal myocardial infarction, revascularization, stroke).Secondary endpoints are defined as decrease of hospitalization due to refractory angina pectoris,the improvements of cardiorespiratory fitness,life quality,as well as angina pectoris. The subjects will be randomized into 2 different groups, HBCR group and control group. After comprehensive evaluation, the orders from CR staff will be given. Besides the routine health education in both groups, the subjects in HBCR group will be further introduced the instructions of exercise training. The effect of HBCR on cardiorespiratory fitness, improvement of angina, cardiac function, quality of life, levels of anxiety and depression, as well as risk factor profile will also be evaluated. The investigators also aim to explore the factors which influence the adherence of subjects to our HBCR program.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Coronary Artery Disease
Keywords
cardiorespiratory fitness, coronary artery disease, cardiac rehabilitation, remote control, major adverse cardiac and cerebrovascular events

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
2000 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Home-based Cardiac Rehabilitation group
Arm Type
Experimental
Arm Description
remote instructed exercise training at home
Arm Title
routine group
Arm Type
No Intervention
Arm Description
no instructed exercise training
Intervention Type
Other
Intervention Name(s)
home-based cardiac rehabilitation
Other Intervention Name(s)
exercise training at home
Intervention Description
The exercise training includes aerobic exercise (fast walking or cycling ,30-40 minutes per day,5-6 times a week), stretching exercise (15 minutes every time, 5-6 times a week), and resistance and balance training (each of 15 minutes every time, twice to 3 times a week).
Primary Outcome Measure Information:
Title
MACCE(death, nonfatal myocardial infarction, revascularization, stroke)
Description
defined as the incidence of composite MACCE.
Time Frame
during 12 months
Secondary Outcome Measure Information:
Title
improvement of hospitalization due to refractory angina pectoris
Description
improvement of hospitalization due to refractory angina pectoris which need to be treated in hospital
Time Frame
during 12 months
Title
improvement of cardiorespiratory fitness
Description
peak oxygen uptake adjusted by body weight measured by cardiopulmonary exercise test
Time Frame
during 12 months
Title
improvement of life quality
Description
measured by medical outcomes study 36-item short form health survey
Time Frame
during 12 months
Title
improvement of angina pectoris
Description
measured by Seattle Angina Questionnaire.
Time Frame
during 12 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
30 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: all of them age range from 30 to 80. coronary artery disease,revascularized with stent deployment. New York Heart Association (NYHA) classification Class I-III. Good cognitive level. Ability to perform aerobic exercise. Understand be able to use a mobile smart phone by himself or with help of family members. Signature of informed consent. The informed consent will be valid for the duration of the trial or until the subject withdraws. Exclusion Criteria (Enrollment): Presence of malignant arrhythmias such as ventricular fibrillation outside the acute phase of Acute myocardial infarction (AMI) (> 24 h after AMI), ventricular tachycardia, Atrioventricular block of 2nd degree and 3rd degree, Atrial fibrilation (FA) in patients with Wolf Parkinson White, fibrillation or paroxysmal atrial flutter with response ventricular quickly and hemodynamic deterioration, premature ventricular contractions increases during exertion, paroxysmal supraventricular tachycardia uncontrolled. Hypotensive response to exercise. acute myocardial infarction within 2 weeks Poorly controlled hypertension baseline,hyperglycemia,respiratory failure. severe pulmonary hypertension acute phase of heart failure Pathology of musculoskeletal, neurological or breathing that impair the ability of prolonged ambulation. Pregnant women. Subjects unable to give informed consent.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Jing Ma, MD,PHD
Phone
86-10-66935316
Email
crystalma_301@126.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Yundai Chen, MD,PHD
Organizational Affiliation
Director of department of Cardiology, Chinese PLA General Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
the First People's Hospital of Yunnan Province
City
Kunming
State/Province
Yunnan
ZIP/Postal Code
650032
Country
China
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
YUNMEI ZHANG, MD
Phone
8613888182536
Email
zym888198@sina.com
First Name & Middle Initial & Last Name & Degree
KE ZHUANG, MD
Phone
8613888901747
Email
zhuangke@trails1.cn

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
15492340
Citation
DeBusk RF, Miller NH, Parker KM, Bandura A, Kraemer HC, Cher DJ, West JA, Fowler MB, Greenwald G. Care management for low-risk patients with heart failure: a randomized, controlled trial. Ann Intern Med. 2004 Oct 19;141(8):606-13. doi: 10.7326/0003-4819-141-8-200410190-00008.
Results Reference
background
PubMed Identifier
8124838
Citation
Haskell WL, Alderman EL, Fair JM, Maron DJ, Mackey SF, Superko HR, Williams PT, Johnstone IM, Champagne MA, Krauss RM, et al. Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP). Circulation. 1994 Mar;89(3):975-90. doi: 10.1161/01.cir.89.3.975.
Results Reference
background
PubMed Identifier
6381770
Citation
Froelicher V, Jensen D, Genter F, Sullivan M, McKirnan MD, Witztum K, Scharf J, Strong ML, Ashburn W. A randomized trial of exercise training in patients with coronary heart disease. JAMA. 1984 Sep 14;252(10):1291-7.
Results Reference
background
PubMed Identifier
1853191
Citation
Newton M, Mutrie N, McArthur JD. The effects of exercise in a coronary rehabilitation programme. Scott Med J. 1991 Apr;36(2):38-41. doi: 10.1177/003693309103600203.
Results Reference
background
PubMed Identifier
23711446
Citation
Conraads VM, Van Craenenbroeck EM, Pattyn N, Cornelissen VA, Beckers PJ, Coeckelberghs E, De Maeyer C, Denollet J, Frederix G, Goetschalckx K, Hoymans VY, Possemiers N, Schepers D, Shivalkar B, Vanhees L. Rationale and design of a randomized trial on the effectiveness of aerobic interval training in patients with coronary artery disease: the SAINTEX-CAD study. Int J Cardiol. 2013 Oct 9;168(4):3532-6. doi: 10.1016/j.ijcard.2013.05.007. Epub 2013 May 24.
Results Reference
background
PubMed Identifier
21799272
Citation
Soga Y, Yokoi H, Amemiya K, Iwabuchi M, Nobuyoshi M. Safety and efficacy of exercise training after coronary stenting in patients with stable coronary artery disease. Circ J. 2011;75(10):2379-86. doi: 10.1253/circj.cj-11-0470. Epub 2011 Jul 28.
Results Reference
background
PubMed Identifier
23174552
Citation
Perez-Terzic CM. Exercise in cardiovascular diseases. PM R. 2012 Nov;4(11):867-73. doi: 10.1016/j.pmrj.2012.10.003.
Results Reference
background

Learn more about this trial

efficAcy and Safety of Home-baSed Cardiac rehabIlitation in ChineSe Revascularized patienTs

We'll reach out to this number within 24 hrs